Does electrical stimulation still have a place in the treatment armamentarium for Bell's palsy?
Myriam Loyo Li,Michelle H. Cameron,Gerd Fabian Volk,Myriam Loyo LiMichelle H. CameronGerd Fabian Volka Facial Nerve Center,Department of Otolaryngology- Head and Neck Surgery,Oregon Health & Science University,Oregon,USAb Department of Neurology,Oregon Health & Science University,MS Center of Excellence-West,VA Portland Health Care System,Portland,OR,USAc Facial-Nerve-Center,Department of Otorhinolaryngology,Head and Neck Surgery,Center of Rare Diseases,Jena University Hospital,Jena,Germany
DOI: https://doi.org/10.1080/14737175.2023.2295426
IF: 4.287
2023-12-19
Expert Review of Neurotherapeutics
Abstract:KEYWORDS: Bell's palsy, an idiopathic facial paralysis associated with peripheral facial (CN VII) nerve dysfunction, is the most common cause of facial paresis or paralysis. It is estimated that one in 60 people will be affected by Bell's palsy in their lifetime. The unilateral partial to complete loss of motor control associated with Bell's palsy results in ipsilateral facial drooping, a distorted appearance, inability to form desired facial expressions, difficulty articulating speech, drooling and difficulty eating, as well as incomplete eye closure and eye dryness that can lead to eye infections, corneal scarring and even permanent vision loss. Bell's palsy can also lead to depression, social anxiety, and isolation [ Citation 1 ].
pharmacology & pharmacy,clinical neurology